About Us
Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological and other disorders. Our pipeline includes our lead drug candidate, CM-AT, for Autism, along with a number of therapies for other neurological conditions.
Learn more about how our research helps patients.
Learn More